From March 13, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on March 16, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.02 CNY | -1.82% |
|
-3.18% | -46.04% |
1st Jan change | Capi. | |
---|---|---|
-46.04% | 787M | |
+51.99% | 803B | |
-5.72% | 351B | |
+18.94% | 324B | |
+11.07% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.59% | 164B | |
-3.65% | 155B |
- Stock Market
- Equities
- 301246 Stock
- News Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
- Tranche Update on Hubei Hongyuan Pharmaceutical Technology Co., Ltd.'s Equity Buyback Plan announced on March 16, 2024.